Results 81 to 90 of about 54,728 (156)

How to measure the effectiveness of healthcare providers acting as an 'anchor institution': a case study of the NHS in Greater Manchester, England. [PDF]

BMJ Open
Wattal V, Camacho C, Gkiouleka A, Ford JA, Munford LA.   +4 more
europepmc   +1 more source

Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity. [PDF]

PLOS Glob Public Health
Rusatira JC, Pal E, Uwimana JB, Khan A, Novoa MD, Suryanarayanan S, Schoukroun-Barnes L, Peterson C, Michtalik H, Kapeta AB, Mukanga D, Ahmed S, Lumpkin M, Preston C.   +13 more
europepmc   +1 more source

Seafood procurement auctions in the presence of origin falsification: Price-only auction versus scoring auction. [PDF]

PLoS One
Piao S, Guo J.
europepmc   +1 more source

Aligning health, industry, and innovation through public procurement. [PDF]

Eur J Public Health
da Fonseca EM, Shadlen KC.
europepmc   +1 more source

Reforming competitive global public health funding: Bridging equity and practice gaps. [PDF]

PLOS Glob Public Health
Ye Y, Fotso JC, Meda N, Eckert E.
europepmc   +1 more source

Operational checks for real-time urinary biomarker measurements for assessment of the quality of deceased donor kidneys. [PDF]

Sci Rep
Barik M, DSouza S, Obeid W, Hu D, Xu S, Doshi M, Mohan S, Gansner E, Marklin G, Olden N, Woodard W, Herczyk W, Philbrook HT, Parikh CR.   +13 more
europepmc   +1 more source

From grassroots to strategy: advancing laboratory sustainability at Utrecht university. [PDF]

RSC Adv
Di Marco G, Heesbeen EJ, Chemtob B, Reiprich JW, Xenaki KAT, van Steenbergen MJ, van den Dikkenberg A, van de Leeuw W, Nelissen AF, Sprangers J, Schell B, Masereeuw R, Carreon JR, Vermonden T.   +13 more
europepmc   +1 more source

Carbapenem-resistant <i>Acinetobacter baumannii</i> in resource-limited ICUs: when 'recommended therapy' is not realistically deliverable. [PDF]

JAC Antimicrob Resist
Saquib Alam M, Khatoon N.
europepmc   +1 more source

Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system. [PDF]

Front Public Health
Hamida JA, Alkhatib NS, Hammour KA, Halloush S, Kurdi A, Balkhi B, Alfayez OM, Mousa R.   +7 more
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source